A pilot trial of the MemorEM device for neurological diseases
Part of Brain & nervous system clinical trials.
This trial tests a device called MemorEM to see how patients with neurological diseases like Alzheimer's or Parkinson's experience it. It aims to understand if the device is comfortable and easy to use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a neurological disease caused by protein clumps, such as Alzheimer's, Parkinson's, or ALS
- You have a caregiver who can help with the treatment and make medical decisions if needed
- You agree to sign the consent form for the study
- You do not have uncontrolled seizures, epilepsy, depression, or other serious mental health conditions
- You do not have metal implants in your head (dental fillings are okay)
- Your blood pressure is controlled with medication
- You do not have significant heart disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a device called MemorEM to see how it works for people with brain diseases that cause memory and thinking problems (like Alzheimer's, Parkinson's, and ALS). It aims to understand your experience with the device.
This study tests whether a pulsed electromagnetic field (PEMF) device can help people with mild to moderate Alzheimer's or related dementias. If you or a loved one has memory loss, this trial looks at a potential new way to support brain health without medication.
This trial tests whether a pulsed electromagnetic field (a non-drug device that uses magnetic pulses) can help people with mild to moderate Alzheimer’s. Participants typically stay on stable Alzheimer’s medicines and follow daily home treatments during the study.
This study tests a device called Neuclare that aims to temporarily boost memory and thinking skills in people with mild cognitive impairment or very early Alzheimer's disease. It could offer a non-drug way to help with daily mental tasks.
This study tests if a new approach (AMPER) can help people with mild to moderate Alzheimer's disease. It looks at how your thinking and daily function change over time.
This Johns Hopkins study tests a personalized brain stimulation device that adjusts in real-time to help people with early-stage Alzheimer's disease improve memory. Researchers will implant electrodes to stimulate the brain based on your brain activity, aiming to strengthen memory function.
Hear when a new Alzheimer's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.